Stocks · Healthcare · Medical - Instruments & Supplies
AtriCure, Inc. ATRC
$55.14 +2.89% Close, Oct 2, 2026 · NASDAQ · Market cap $2.80B
High qualityStrong trendLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 2.4% from -6.8% a year earlier.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +100.0%).
- The stock is in an uptrend: above its 200-day average for 50 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 41%
- FCF growth (TTM, YoY)Top 3%
- Revenue growth, 3-year CAGRTop 35%
- Revenue growth accelerationBottom 41%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 29%
- Gross marginTop 35%
- Operating marginTop 39%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 42%
- Net debt / EBITDA (lower is better)Top 8%
- Interest coverTop 37%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 29%
- Free-cash-flow yieldTop 29%
- EBITDA / enterprise valueTop 35%
- Sales / enterprise valueBottom 49%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 32%
- 6-month returnTop 10%
- 1-year return vs S&P 500Top 24%
- Distance from 52-week highTop 16%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyTop 27%
- Upside to consensus price targetBottom 13%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 25%
- Maximum drawdown, 3 yearsTop 28%
- Beta vs S&P 500 (lower is better)Top 25%
- Net debt / EBITDA (lower is better)Top 8%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 15.0% | 13.9% | ↓ |
| Gross margin | 74.7% | 76.2% | ↑ |
| Operating margin | -6.8% | 2.4% | ↑ |
| FCF margin | 1.7% | 10.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 13.9% | 15.0% | ↓ | Top 41% |
| Gross margin | 76.2% | 74.7% | ↑ | Top 35% |
| Operating margin | 2.4% | -6.8% | ↑ | Top 39% |
| Net margin | 1.9% | -7.3% | ↑ | — |
| Free-cash-flow margin | 10.2% | 1.7% | ↑ | — |
| Return on invested capital | 2.0% | — | Top 29% | |
| Revenue growth, 3-year CAGR | 17.4% | — | Top 35% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -8.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 8.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +7.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -3.56×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 2.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.20%
- Shareholder yield
- 0.20%
- Share count change, 1 year
- +3.2%
- Share count change, 3-year CAGR
- +2.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 27, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +0.2%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $57.29
- Target vs current price
- +3.9%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 90%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 23, 2026 | +10878.4% | -1.6% | +22.0% | +42.0% | — |
| May 5, 2026 | +103.1% | +2.1% | -8.6% | -10.1% | +39.5% |
| Feb 17, 2026 | +249.9% | +1.0% | -2.6% | -6.8% | -18.3% |
| Oct 29, 2025 | +90.9% | -2.8% | -10.2% | +5.6% | +5.7% |
| Jul 29, 2025 | +13.3% | -4.5% | +9.4% | +13.9% | +11.4% |
| Apr 29, 2025 | +44.0% | +2.9% | -13.7% | +1.0% | -10.4% |
| Feb 12, 2025 | -43.5% | +2.0% | -6.0% | -21.2% | -24.9% |
| Oct 29, 2024 | +15.0% | +2.4% | +17.1% | +25.3% | +42.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 23, 2026 | $0.18 | -$0.00 | +10878.4% | $153.6M |
| May 5, 2026 | $0.00 | -$0.07 | +103.1% | $141.2M |
| Feb 17, 2026 | $0.06 | -$0.04 | +249.9% | $140.5M |
| Oct 29, 2025 | -$0.01 | -$0.11 | +90.9% | $134.3M |
| Jul 29, 2025 | -$0.13 | -$0.15 | +13.3% | $136.1M |
| Apr 29, 2025 | -$0.14 | -$0.25 | +44.0% | $123.6M |
| Feb 12, 2025 | -$0.33 | -$0.23 | -43.5% | $124.3M |
| Oct 29, 2024 | -$0.17 | -$0.20 | +15.0% | $115.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 259.8× | — | — | Top 29% |
| P/E (forward) | 515.6× | — | — | — |
| EV / EBITDA | 99.7× | — | — | Top 35% |
| EV / Sales | 4.75× | — | — | Bottom 49% |
| Free-cash-flow yield | 2.07% | — | — | Top 29% |
| Earnings yield | 0.38% | — | — | Top 29% |
P/E over the past five years
Range 42.6× – 176.1× since Sep 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 74
- Days above the 200-day average
- 50
- 50-day average slope (20 days)
- +24.0%
- 200-day average slope (20 days)
- +5.5%
- Distance from 50-day average
- +12.3%
- Distance from 200-day average
- +51.7%
- RSI (14)
- 53.1
- Relative volume
- 0.99×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 42.2%
- Volatility vs own 5-year history
- 28th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.67
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -9.3%
- Maximum drawdown, 3 years
- -54.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 5, 2021 | Jun 17, 2024 | -77.2% | 655 days | Not yet recovered |
| Jul 30, 2021 | Oct 4, 2021 | -20.4% | 45 days | 23 days (Nov 4, 2021) |
| Oct 9, 2020 | Oct 30, 2020 | -16.4% | 15 days | 14 days (Nov 19, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.80B
- P/E (TTM)
- 259.8
- EPS, diluted (TTM)
- $0.21
- Revenue (TTM)
- $569.6M
- 52-week range
- $25.36 – $61.70
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $274.3M | $330.4M | $399.2M | $465.3M | $534.5M |
| Gross profit | $205.9M | $245.9M | $300.4M | $347.5M | $397.7M |
| Operating income | $55.2M | -$42.7M | -$26.7M | -$40.0M | -$3.4M |
| Net income | $50.2M | -$46.5M | -$30.4M | -$44.7M | -$11.4M |
| EPS (diluted) | $1.09 | -$1.02 | -$0.66 | -$0.95 | -$0.24 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $115.9M | $124.3M | $123.6M | $136.1M | $134.3M | $140.5M | $141.2M | $153.6M |
| Net income | -$7.9M | -$15.6M | -$6.7M | -$6.2M | -$267,000 | $1.8M | $108,000 | $9.0M |
| EPS (diluted) | -$0.17 | -$0.33 | -$0.14 | -$0.13 | -$0.01 | $0.04 | $0.00 | $0.18 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$13.8M | -$22.1M | $4.5M | $12.2M | $57.3M |
| Capital expenditure | -$9.8M | -$16.9M | -$42.0M | -$23.5M | -$9.1M |
| Free cash flow | -$23.5M | -$39.0M | -$37.5M | -$11.3M | $48.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$18.0M | -$12.2M | -$6.6M | -$7.0M | -$3.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $167.8M
- Total assets
- $676.6M
- Total liabilities
- $160.2M
- Total debt
- $71.0M
- Net debt
- -$96.7M
- Shareholders’ equity
- $516.4M
As of Jun 30, 2026 (filed Jul 27, 2026).
Short interest
- Shares sold short
- 4,279,518
- Days to cover
- 3.62
- Change vs previous report
- +3.3%
FINRA short interest, settlement date Sep 15, 2026.